Patent Application
Provisional
App. No. 63/341,367
· Confirmation No. 4225
PROGNOSIS AND TREATMENT OF MOLECULAR SUBTYPES OF PROSTATE CANCER
Applicant:
Veracyte SD, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2022-05-24 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-05-12 | ADS |
Application Data Sheet | 8 | View | |
| 2022-05-12 | SPEC |
Specification | 60 | View | |
| 2022-05-12 | CLM |
Claims | 4 | View | |
| 2022-05-12 | ABST |
Abstract | 1 | View | |
| 2022-05-12 | DRW |
Drawings-only black and white line drawings | 12 | View | |
| 2022-05-12 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-05-12 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Elai Davicioni
San Diego, CA
Yang Liu
Vancouver, CANADA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 20995
- Docket No.
- GENDX.028PR
- Confirmation No.
- 4225
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/341,367
- Filed
- 2022-05-12
External Links